Dr. Mara Okshteyn, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 200 W Magee Rd, Suite 140, Oro Valley, AZ 85704 Phone: 520-812-7180 Fax: 855-523-4050 |
News Archive
The south and southwest sides of Chicago suffer the most in terms of residents' health and access to basic health resources, according to a new study of 77 Chicago neighborhoods.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced the launch of a free service available through its Emdeon Office solution. Healthcare providers will now have the ability to submit workers' compensation and automobile medical bills and related attachments electronically through the Emdeon Office EZBill solution regardless of which practice management software they are currently using.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that data from its Phase I/II study of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published in Nature Medicine.
Phenomix Corporation today announced it has begun administering subjects in a Phase 1a clinical trial of PHX1766, the company's internally discovered, orally available NS3/4A protease inhibitor for the treatment of chronic hepatitis C virus (HCV) infection.
› Verified 7 days ago